Eli Lilly and Company and Biolojic Design recently announced a research agreement to discover and develop potential novel antibody therapies for the treatment of diabetes.
Read more here.
Eli Lilly and Company and Biolojic Design recently announced a research agreement to discover and develop potential novel antibody therapies for the treatment of diabetes.
Read more here.